Clemastine fumarate as an antipruritic agent in pruritic cats: results of an open clinical trial.

Abstract

Clemastine fumarate was administered to 10 presumed or proven atopic cats to determine its efficacy in controlling their pruritus. Initially, each cat received 0.34 mg orally every twelve hours for 14 days. When none responded satisfactorily, the dosage was increased to 0.68 mg/cat every twelve hours. At that dosage, the pruritus in five cats (50%) was eliminated. Diarrhea was seen in one cat. Under the conditions of the study, clemastine was a useful antipruritic agent for the cat.

• Authors: W H Miller Jr, D W Scott
• Journal: The Canadian veterinary journal = La revue veterinaire canadienne (Can Vet J) Vol. 35 Issue 8 Pg. 502-4 (Aug 1994) ISSN: 0008-5286 [Print] Canada
• PMID: 7954223 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)

Chemical References

• Clemastine

Topics

• Administration, Oral
• Animals
• Cat Diseases (prevention & control)
• Cats
• Clemastine (administration & dosage)
• Drug Administration Schedule
• Female
• Male
• Pruritus (prevention & control, veterinary)
• Treatment Outcome